ConductScience.org, home

Paper14969769

Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.

Filaci G and 13 others. Hum Immunol, 2004. Cited by 139 papers, by iCite.

Cite this record

ConductScience Library. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Papers, record 14969769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14969769

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
PubMed
Journal
Hum Immunol
PubMed
Year
2004
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
139
iCite
Relative citation ratio, by iCite
2.56
iCite
Revised in PubMed
2021-01-02
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Filaci GGilberto
2Fravega MMarco
3Negrini SSimone
4Procopio FFrancesco
5Fenoglio DDaniela
6Rizzi MMarta
7Brenci SSabrina
8Contini PPaola
9Olive DDaniel
10Ghio MMassimo
11Setti MMaurizio
12Accolla RSRoberto S
13Puppo FFrancesco
14Indiveri FFrancesco

Source PubMed

Download CSV of authors

Topics34

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD28 AntigensMajor topic
CD8-Positive T-LymphocytesMajor topic
Immune ToleranceMajor topic
T-LymphocytesMajor topic
T-Lymphocytes, RegulatoryMajor topic
Antibodies, Monoclonal
Antibody-Dependent Cell Cytotoxicity
Antigen Presentation
CD3 Complex
CD4-Positive T-Lymphocytes
CD8 Antigens
Cell Communication
Cell Differentiation
Cell Proliferation
Coculture Techniques
Culture Media, Conditioned
Dendritic Cells
Flow Cytometry
Granulocyte-Macrophage Colony-Stimulating Factor
Histocompatibility Antigens Class I
Humans
Interleukin-10
Interleukin-2
Leukocyte Common Antigens
Lymphocyte Activation
Monocytes
Receptors, Antigen, T-Cell, alpha-beta
Receptors, CCR7
Receptors, Chemokine
Receptors, Interleukin
Receptors, Interleukin-10
T-Lymphocytes, Cytotoxic
Tuberculin
Tumor Necrosis Factor Receptor Superfamily, Member 7

Source PubMed

Download CSV of topics

Cited by71

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.

PMIDTitleJournalYearIn PapersSource
41373714TCR-Based Antigen-Specific Therapy for Type 1 Diabetes Mellitus: From Editing Autoreactive Clones to Tolerance Induction.Int J Mol Sci2025https://conductscience.org/library/papers/41373714PubMed
41349560CD8+ Regulatory T Cells.Annu Rev Immunol2026https://conductscience.org/library/papers/41349560PubMed
40312697
Comparison of circulating immune signatures across different consensus molecular subtypes (CMS) and between left- and right-sided lesions in stage II colorectal cancer using single-cell mass cytometry.
J Transl Med2025https://conductscience.org/library/papers/40312697PubMed
39592626Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study.Nat Commun2024https://conductscience.org/library/papers/39592626PubMed
39085655Characterization of novel CD8+ regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease.Cell Mol Life Sci2024https://conductscience.org/library/papers/39085655PubMed
36189271OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.Front Immunol2022https://conductscience.org/library/papers/36189271PubMed
36105795Nomogram based on circulating lymphocyte subsets for predicting radiation pneumonia in esophageal squamous cell carcinoma.Front Immunol2022https://conductscience.org/library/papers/36105795PubMed
35954318Radiomic Signatures Associated with CD8+ Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study.Cancers (Basel)2022https://conductscience.org/library/papers/35954318PubMed
35258440Systemic sclerosis and vaccinations: a three-year register-based cohort study about vaccination rate and uptake from Liguria referral center, northwest Italy.Hum Vaccin Immunother2022https://conductscience.org/library/papers/35258440PubMed
35055071Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent.Int J Mol Sci2022https://conductscience.org/library/papers/35055071PubMed
34899714Newly Found Peacekeeper: Potential of CD8+ Tregs for Graft-Versus-Host Disease.Front Immunol2021https://conductscience.org/library/papers/34899714PubMed
34831195Harnessing CD8+CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease.Cells2021https://conductscience.org/library/papers/34831195PubMed
34335631
CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
Front Immunol2021https://conductscience.org/library/papers/34335631PubMed
34066538Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34066538PubMed
33072584Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis.Front Oncol2020https://conductscience.org/library/papers/33072584PubMed
32774487Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies.Oncol Lett2020https://conductscience.org/library/papers/32774487PubMed
31199313
Stimulation of Nucleotide Oligomerization Domain and Toll-Like Receptors 2 to Enhance the Effect of Bacillus Calmette Guerin Immunization for Prevention of Mycobacterium Tuberculosis Infection: Protocol for a Series of Preclinical Randomized Controlled Trials.
JMIR Res Protoc2019https://conductscience.org/library/papers/31199313PubMed
31067796Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly Patients.Int J Mol Sci2019https://conductscience.org/library/papers/31067796PubMed
30728151Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer.Cancer Immunol Res2019https://conductscience.org/library/papers/30728151PubMed
30459765Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV.Front Immunol2018https://conductscience.org/library/papers/30459765PubMed

See all 71 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14969769

GET https://conductscience.org/api/papers/v1/14969769/cited_by?page=2